Ways of Regulating Drugs in the 19th and 20th Centuries

Hardcover | December 7, 2012

EditorJean-paul Gaudillière, Volker Hess

not yet rated|write a review

Among industrial goods, pharmaceuticals are those for which the concept of regulation has been most often applied. One reason for the pervasiveness of the idea of regulation is that therapeutic agents are not like other goods. Their sale and purchase constitute a very distinct market, the control and oversight of which is viewed as a means to protect public health and considered as a duty of the state since the early nineteenth century. Drug regulation thus usually focuses on actions taken by political bodies to control the technical activities of drug makers. As it developed into a large industry, drug making has become the focus of highly visible conflicts between capitalistic firms, physicians, patients, and public authorities. Other forms and targets of drug government have emerged, which not only target sales and marketing, but deal with the entire trajectory of drugs, i.e. research and development, mass production and preparation, circulation and prescription and routine clinical work. The essays assembled in this volume share the perspective that the historiography of science, technology, and medicine, therefore, needs a broader approach toward regulation; an approach taking into account the distinct social worlds involved in regulation, the forms of evidence and expertise mobilized, and the means of intervention chosen in order to tame drugs in factories, offices, consulting rooms and courts. Focusing on case studies, the volume explores the 'ways of regulating drugs', which surfaced in the 19th and 20th century, and play a central role in the present world of science, market and medicine.

Pricing and Purchase Info

$143.00

In stock online
Ships free on orders over $25

From the Publisher

Among industrial goods, pharmaceuticals are those for which the concept of regulation has been most often applied. One reason for the pervasiveness of the idea of regulation is that therapeutic agents are not like other goods. Their sale and purchase constitute a very distinct market, the control and oversight of which is viewed as a m...

JEAN-PAUL GAUDILLIERE is a senior researcher at the Institut National de la Santé et de la Recherche Médicale,director of the Centre de Recherches Médecine Sciences Santé et Société. His research interests have first focused on the molecularization of biology during the 20th century and later on the reconfiguration of medical research...

other books by Jean-paul Gaudillière

Ways of Regulating Drugs in the 19th and 20th Centuries
Ways of Regulating Drugs in the 19th and 20th Centuries

Kobo ebook|Dec 3 2012

$101.29 online$131.52list price(save 22%)
see all books by Jean-paul Gaudillière
Format:HardcoverDimensions:344 pages, 10.82 × 5.72 × 1.02 inPublished:December 7, 2012Publisher:Palgrave MacmillanLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0230301967

ISBN - 13:9780230301962

Look for similar items by category:

Customer Reviews of Ways of Regulating Drugs in the 19th and 20th Centuries

Reviews

Extra Content

Table of Contents

List of Illustrations
List of Tables
Notes on Contributors
General Introduction; J.P.Gaudillière & V.Hess
Secrets, Bureaucracy and the Public: Drug Regulation in Prussia in the 19th century; V.Hess
Making Salvarsan. Experimental therapy and the development and marketing of Salvarsan at the interface between science, clinic, industry and public health; A.Hüntelmann
Professional and Industrial Regulation in France and Germany: the Trajectories of Plant Extracts; J.P.Gaudillière
Making Risks Visible: The Science, Politics and Regulation of Adverse Drug Reactions; H.Marks
Regulating Drugs, Regulating Diseases: Consumerism and the U.S. Tolbutamide Controversy; J.Greene
Thalidomide, Drug Safety Regulation and the British Pharmaceutical Industry: the Case of Imperial Chemical Industries; V.Quirke
What's in a pill? On the Informational Enrichment of Anti-cancer Drugs; A.Cambrosio, P.Keating & A.Mogoutov
Treating Health Risks or Putting Healthy Women at Risk: Controversies around Chemoprevention of Breast Cancer; I.Löwy
AZT and Drug Regulatory Reform in the Late Twentieth Century US; D.Messner
Professional, Industrial and Court Regulation of Drugs: The 1953 Stalinon Case and Pharmaceutical Reform in Postwar France; C.Bonah
Managing Double Binds in the Pharmaceutical Prescription Market: The Case of Halcion; T.Pieters & S.Snelders
Pharmaceutical Patent Law In-the-Making: Opposition and Legal Action by States, Citizens and Generics Laboratories in Brazil and India; M.Cassier